NRG Oncology abstract considered “best of ASCO” for 2024 shows difference in outcomes for node-negative versus node-positive pancreatic cancer patients when adding chemoradiation to systemic therapy
NRG Oncology recently reported the results from the radiotherapy randomization, which was the second step of their NRG-RTOG 0848 clinical ...






